Cargando…

The Omega-3 Polyunsaturated Fatty Acid Docosahexaenoic Acid (DHA) Reverses Corticosterone-Induced Changes in Cortical Neurons

BACKGROUND: Chronic exposure to the glucocorticoid hormone corticosterone exerts cellular stress-induced toxic effects that have been associated with neurodegenerative and psychiatric disorders. Docosahexaenoic acid is a polyunsaturated fatty acid that has been shown to be of benefit in stress-relat...

Descripción completa

Detalles Bibliográficos
Autores principales: Pusceddu, Matteo M., Nolan, Yvonne M., Green, Holly F., Robertson, Ruairi C., Stanton, Catherine, Kelly, Philip, Cryan, John F., Dinan, Timothy G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4926793/
https://www.ncbi.nlm.nih.gov/pubmed/26657646
http://dx.doi.org/10.1093/ijnp/pyv130
_version_ 1782440183830937600
author Pusceddu, Matteo M.
Nolan, Yvonne M.
Green, Holly F.
Robertson, Ruairi C.
Stanton, Catherine
Kelly, Philip
Cryan, John F.
Dinan, Timothy G.
author_facet Pusceddu, Matteo M.
Nolan, Yvonne M.
Green, Holly F.
Robertson, Ruairi C.
Stanton, Catherine
Kelly, Philip
Cryan, John F.
Dinan, Timothy G.
author_sort Pusceddu, Matteo M.
collection PubMed
description BACKGROUND: Chronic exposure to the glucocorticoid hormone corticosterone exerts cellular stress-induced toxic effects that have been associated with neurodegenerative and psychiatric disorders. Docosahexaenoic acid is a polyunsaturated fatty acid that has been shown to be of benefit in stress-related disorders, putatively through protective action in neurons. METHODS: We investigated the protective effect of docosahexaenoic acid against glucocorticoid hormone corticosterone-induced cellular changes in cortical cell cultures containing both astrocytes and neurons. RESULTS: We found that glucocorticoid hormone corticosterone (100, 150, 200 μM) at different time points (48 and 72 hours) induced a dose- and time-dependent reduction in cellular viability as assessed by methyl thiazolyl tetrazolium. Moreover, glucocorticoid hormone corticosterone (200 μM, 72 hours) decreased the percentage composition of neurons while increasing the percentage of astrocytes as assessed by βIII-tubulin and glial fibrillary acidic protein immunostaining, respectively. In contrast, docosahexaenoic acid treatment (6 μM) increased docosahexaenoic acid content and attenuated glucocorticoid hormone corticosterone (200 μM)-induced cell death (72 hours) in cortical cultures. This translates into a capacity for docosahexaenoic acid to prevent neuronal death as well as astrocyte overgrowth following chronic exposure to glucocorticoid hormone corticosterone. Furthermore, docosahexaenoic acid (6 μM) reversed glucocorticoid hormone corticosterone-induced neuronal apoptosis as assessed by terminal deoxynucleotidyl transferase–mediated nick-end labeling and attenuated glucocorticoid hormone corticosterone-induced reductions in brain derived neurotrophic factor mRNA expression in these cultures. Finally, docosahexaenoic acid inhibited glucocorticoid hormone corticosterone-induced downregulation of glucocorticoid receptor expression on βIII- tubulin-positive neurons. CONCLUSIONS: This work supports the view that docosahexaenoic acid may be beneficial in ameliorating stress-related cellular changes in the brain and may be of value in psychiatric disorders.
format Online
Article
Text
id pubmed-4926793
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-49267932016-07-05 The Omega-3 Polyunsaturated Fatty Acid Docosahexaenoic Acid (DHA) Reverses Corticosterone-Induced Changes in Cortical Neurons Pusceddu, Matteo M. Nolan, Yvonne M. Green, Holly F. Robertson, Ruairi C. Stanton, Catherine Kelly, Philip Cryan, John F. Dinan, Timothy G. Int J Neuropsychopharmacol Research Article BACKGROUND: Chronic exposure to the glucocorticoid hormone corticosterone exerts cellular stress-induced toxic effects that have been associated with neurodegenerative and psychiatric disorders. Docosahexaenoic acid is a polyunsaturated fatty acid that has been shown to be of benefit in stress-related disorders, putatively through protective action in neurons. METHODS: We investigated the protective effect of docosahexaenoic acid against glucocorticoid hormone corticosterone-induced cellular changes in cortical cell cultures containing both astrocytes and neurons. RESULTS: We found that glucocorticoid hormone corticosterone (100, 150, 200 μM) at different time points (48 and 72 hours) induced a dose- and time-dependent reduction in cellular viability as assessed by methyl thiazolyl tetrazolium. Moreover, glucocorticoid hormone corticosterone (200 μM, 72 hours) decreased the percentage composition of neurons while increasing the percentage of astrocytes as assessed by βIII-tubulin and glial fibrillary acidic protein immunostaining, respectively. In contrast, docosahexaenoic acid treatment (6 μM) increased docosahexaenoic acid content and attenuated glucocorticoid hormone corticosterone (200 μM)-induced cell death (72 hours) in cortical cultures. This translates into a capacity for docosahexaenoic acid to prevent neuronal death as well as astrocyte overgrowth following chronic exposure to glucocorticoid hormone corticosterone. Furthermore, docosahexaenoic acid (6 μM) reversed glucocorticoid hormone corticosterone-induced neuronal apoptosis as assessed by terminal deoxynucleotidyl transferase–mediated nick-end labeling and attenuated glucocorticoid hormone corticosterone-induced reductions in brain derived neurotrophic factor mRNA expression in these cultures. Finally, docosahexaenoic acid inhibited glucocorticoid hormone corticosterone-induced downregulation of glucocorticoid receptor expression on βIII- tubulin-positive neurons. CONCLUSIONS: This work supports the view that docosahexaenoic acid may be beneficial in ameliorating stress-related cellular changes in the brain and may be of value in psychiatric disorders. Oxford University Press 2015-12-12 /pmc/articles/PMC4926793/ /pubmed/26657646 http://dx.doi.org/10.1093/ijnp/pyv130 Text en © The Author 2015. Published by Oxford University Press on behalf of CINP. http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Research Article
Pusceddu, Matteo M.
Nolan, Yvonne M.
Green, Holly F.
Robertson, Ruairi C.
Stanton, Catherine
Kelly, Philip
Cryan, John F.
Dinan, Timothy G.
The Omega-3 Polyunsaturated Fatty Acid Docosahexaenoic Acid (DHA) Reverses Corticosterone-Induced Changes in Cortical Neurons
title The Omega-3 Polyunsaturated Fatty Acid Docosahexaenoic Acid (DHA) Reverses Corticosterone-Induced Changes in Cortical Neurons
title_full The Omega-3 Polyunsaturated Fatty Acid Docosahexaenoic Acid (DHA) Reverses Corticosterone-Induced Changes in Cortical Neurons
title_fullStr The Omega-3 Polyunsaturated Fatty Acid Docosahexaenoic Acid (DHA) Reverses Corticosterone-Induced Changes in Cortical Neurons
title_full_unstemmed The Omega-3 Polyunsaturated Fatty Acid Docosahexaenoic Acid (DHA) Reverses Corticosterone-Induced Changes in Cortical Neurons
title_short The Omega-3 Polyunsaturated Fatty Acid Docosahexaenoic Acid (DHA) Reverses Corticosterone-Induced Changes in Cortical Neurons
title_sort omega-3 polyunsaturated fatty acid docosahexaenoic acid (dha) reverses corticosterone-induced changes in cortical neurons
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4926793/
https://www.ncbi.nlm.nih.gov/pubmed/26657646
http://dx.doi.org/10.1093/ijnp/pyv130
work_keys_str_mv AT pusceddumatteom theomega3polyunsaturatedfattyaciddocosahexaenoicaciddhareversescorticosteroneinducedchangesincorticalneurons
AT nolanyvonnem theomega3polyunsaturatedfattyaciddocosahexaenoicaciddhareversescorticosteroneinducedchangesincorticalneurons
AT greenhollyf theomega3polyunsaturatedfattyaciddocosahexaenoicaciddhareversescorticosteroneinducedchangesincorticalneurons
AT robertsonruairic theomega3polyunsaturatedfattyaciddocosahexaenoicaciddhareversescorticosteroneinducedchangesincorticalneurons
AT stantoncatherine theomega3polyunsaturatedfattyaciddocosahexaenoicaciddhareversescorticosteroneinducedchangesincorticalneurons
AT kellyphilip theomega3polyunsaturatedfattyaciddocosahexaenoicaciddhareversescorticosteroneinducedchangesincorticalneurons
AT cryanjohnf theomega3polyunsaturatedfattyaciddocosahexaenoicaciddhareversescorticosteroneinducedchangesincorticalneurons
AT dinantimothyg theomega3polyunsaturatedfattyaciddocosahexaenoicaciddhareversescorticosteroneinducedchangesincorticalneurons
AT pusceddumatteom omega3polyunsaturatedfattyaciddocosahexaenoicaciddhareversescorticosteroneinducedchangesincorticalneurons
AT nolanyvonnem omega3polyunsaturatedfattyaciddocosahexaenoicaciddhareversescorticosteroneinducedchangesincorticalneurons
AT greenhollyf omega3polyunsaturatedfattyaciddocosahexaenoicaciddhareversescorticosteroneinducedchangesincorticalneurons
AT robertsonruairic omega3polyunsaturatedfattyaciddocosahexaenoicaciddhareversescorticosteroneinducedchangesincorticalneurons
AT stantoncatherine omega3polyunsaturatedfattyaciddocosahexaenoicaciddhareversescorticosteroneinducedchangesincorticalneurons
AT kellyphilip omega3polyunsaturatedfattyaciddocosahexaenoicaciddhareversescorticosteroneinducedchangesincorticalneurons
AT cryanjohnf omega3polyunsaturatedfattyaciddocosahexaenoicaciddhareversescorticosteroneinducedchangesincorticalneurons
AT dinantimothyg omega3polyunsaturatedfattyaciddocosahexaenoicaciddhareversescorticosteroneinducedchangesincorticalneurons